Argent BioPharma Limited (MXC.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 01:47PM BST
Currency in GBp
Valuation measures4
| Market cap (intra-day) | 9.60M |
| Enterprise value | 6.49M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.37 |
| Price/book (mrq) | 14.21 |
| Enterprise value/revenue | 3.89 |
| Enterprise value/EBITDA | -0.42 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.03 |
| 52-week change 3 | -95.11% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 470.00 |
| 52-week low 3 | 0.00 |
| 50-day moving average 3 | 20.07 |
| 200-day moving average 3 | 60.26 |
Share statistics
| Avg vol (3-month) 3 | 26.24k |
| Avg vol (10-day) 3 | 737 |
| Shares outstanding 5 | 43.85M |
| Implied shares outstanding 6 | 44.28M |
| Float 8 | 20.86M |
| % held by insiders 1 | 8.17% |
| % held by institutions 1 | 1.24% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:1000 |
| Last split date 3 | 02 Nov 2023 |
Financial highlights
Currency in AUD.Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,343.42% |
Management effectiveness
| Return on assets (ttm) | -58.96% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 1.32M |
| Revenue per share (ttm) | 0.10 |
| Quarterly revenue growth (yoy) | -77.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -14.44M |
| Net income avi to common (ttm) | -17.02M |
| Diluted EPS (ttm) | -1.66 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 6.48M |
| Total cash per share (mrq) | 0.18 |
| Total debt (mrq) | 9.65M |
| Total debt/equity (mrq) | 1,436.12% |
| Current ratio (mrq) | 0.75 |
| Book value per share (mrq) | 0.04 |
Cash flow statement
| Operating cash flow (ttm) | -13.14M |
| Levered free cash flow (ttm) | -6.57M |
© 2024 Yahoo. All rights reserved.